(6α,11β,16β)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione
Product Name |
(6α,11β,16β)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione
|
Product Code |
DA-H001-b
|
Chemical name |
(6α,11β,16β)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione
|
Synonyms |
Halobetasol Propionate; Miracorten; Ulobetasol Propionate; Ultravate; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl Propionate; Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6α,11β,16β)-;
|
Impurity |
NA
|
CAS Number |
66852-54-8
|
Alternate CAS # |
NA
|
Molecular form |
C25H31ClF2O5
|
Appearance |
White to Off-White Solid
|
Melting Point |
NA
|
Mol. Weight |
484.96
|
Storage |
2-8°C Refrigerator
|
Solubility |
NA
|
Stability |
NA
|
Category |
intermediates,impurities,metabolites,pharmaceutical standards,Fine Chemicals,peptides
|
Boiling Point |
NA
|
Applications |
Anti-inflammatory; a dermatologic agent commonly used to treat psoriasis
|
Dangerous Goods Info |
NA
|
References |
NA
|
Extra Notes |
NA
|
Documents (MSDS) |
No Data Available
|
Keywords |
NA |